XILIO THERAPEUTICS INC. - COMMON STOCK
0.9722
27-December-24 16:45:00
15 minutes delayed
Stocks
-0.0028
-0.29%
Today's range
0.9650 - 1.0500
ISIN
N/A
Source
NASDAQ
-
Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President
16 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the H.C. Wainwright Global Investment Conference
18 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer
17 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
12 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
07 Apr 2022 06:30:00 By Nasdaq GlobeNewswire
-
01 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Participate in the Cowen 42nd Annual Healthcare Conference
28 Feb 2022 06:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Participate in the Guggenheim 4th Annual Oncology Day
03 Feb 2022 06:30:00 By Nasdaq GlobeNewswire
-
20 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
06 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
02 Dec 2021 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Closing of Initial Public Offering
26 Oct 2021 16:05:00 By Nasdaq GlobeNewswire